PANTHERx Pharmacy and RxCrossroads by McKesson Collaborate to Streamline the Channel for Precision Medicine Therapies

PANTHERx Specialty Pharmacy announced their collaborative program to simplify the channel for precision medicine therapies. Recognizing a significant unmet need for cell and gene therapy programs...

Pharmintech 2019: Big increase in International Participation Expected

The nutritional and biotech sectors, medical devices, personal care products and, more broadly, the entire pharmaceutical industry are the focus of the upcoming edition of Pharmintech.

KemPharm Enhances Pipeline with the Addition of KP879 treatment

KemPharm, Inc. the addition of a new product candidate, KP879, which the company plans to develop as an extended-duration, agonist replacement therapy for the treatment of Stimulant Use Disorder...

AstraZeneca Provides update on the Phase III MYSTIC trial of Imfinzi and Tremelimumab in Stage IV

AstraZeneca and MedImmune, its global biologics research and development arm, announced final overall survival (OS) results for the Phase III MYSTIC trial. A randomised, open label, multi centre, global trial...

Quanticate Sponsors Research into Response Adaptive Trial Design

Quanticate, a data-focused clinical research organisation (CRO), has announced that it is partnering with Lancaster University to sponsor a STOR i PhD project. The partnership will see Quanticate support

New Analyses on Mortality from the 18,924 Patient odyssey outcomes trial

Regeneron Pharmaceuticals and Sanofi announced that new analyses on mortality from the 18,924 patient ODYSSEY OUTCOMES trial were presented at the American Heart Association Scientific Sessions 2018.

For Advertising Queries:

Please e-mail : kathryn@worldpharmatoday.com
or
call to: + 91 88268 49084

If you like to receive our latest Media Pack / Editorial Calendar please click here

For the latest visit: www.worldpharmatoday.com